KRT18 and breast cancer: In Shi et al.’s study, compared with the non-metastatic breast cancer cell line MCF-7, the highly metastatic MDA-MB-231 and drug-resistant MCF-7/MX cell lines showed more fibroblast morphology and lower K18 expression (82).